Cite
HARVARD Citation
Cosnes, J. et al. (2016). Adalimumab or infliximab as monotherapy, or in combination with an immunomodulator, in the treatment of Crohn's disease. Alimentary pharmacology & therapeutics. 44 (10), pp. 1102-1113. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Cosnes, J. et al. (2016). Adalimumab or infliximab as monotherapy, or in combination with an immunomodulator, in the treatment of Crohn's disease. Alimentary pharmacology & therapeutics. 44 (10), pp. 1102-1113. [Online].